CN101033487A - Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension - Google Patents

Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension Download PDF

Info

Publication number
CN101033487A
CN101033487A CN 200610056749 CN200610056749A CN101033487A CN 101033487 A CN101033487 A CN 101033487A CN 200610056749 CN200610056749 CN 200610056749 CN 200610056749 A CN200610056749 A CN 200610056749A CN 101033487 A CN101033487 A CN 101033487A
Authority
CN
China
Prior art keywords
polymorphic
gene
essential hypertension
klk1
relevant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610056749
Other languages
Chinese (zh)
Other versions
CN101033487B (en
Inventor
顾东风
赵维艳
王来元
李宏帆
王亚平
陈恕凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese Academy of Medical Sciences CAMS
Sinogenomax Co Ltd
Fuwai Hospital of CAMS and PUMC
Original Assignee
Sinogenomax Co Ltd
Fuwai Hospital of CAMS and PUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinogenomax Co Ltd, Fuwai Hospital of CAMS and PUMC filed Critical Sinogenomax Co Ltd
Priority to CN2006100567493A priority Critical patent/CN101033487B/en
Publication of CN101033487A publication Critical patent/CN101033487A/en
Application granted granted Critical
Publication of CN101033487B publication Critical patent/CN101033487B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for detecting KLK1gene rs5517 polymorphism relating to essential hypertension. The method includes detecting A/G polymorphism located at 3812 bp of KLK1 gene coding sequence, in which, the distributed frequency of allele A has positive correlation with the risk rate of essential hypertension. The invention also involves the kits to detect rs5517 polymorphism of KLK1 gene.

Description

Detect the KLK1 gene rs5517 polymorphic method relevant with essential hypertension
Technical field
The present invention relates to a kind of essential hypertension dependency gene and detection method and purposes.More particularly, the present invention relates to KLK1 gene rs5517 polymorphic detection method and the purposes relevant, for example the purposes in the reagent of preparation hypertensive reagent of diagnosing primary or judgement trouble essential hypertension relative risk with essential hypertension.The invention still further relates to and detect the relevant polymorphic test kit of KLK1 gene rs5517 of essential hypertension.
Background technology
The tissue kallikrein gene English name is kallikrein 1, and renal/pancreas/salivary (abbreviation: KLK1), its protein product: tissue kallikrein.KLK1 gene clone in 1988 is positioned human chromosome 19q13.3, is about 5kb, comprises 5 exons.
Kallikrein is one group of serine protease that is present in different tissues and the body fluid, comprises plasma kallikrein and tissue kallikrein.Tissue kallikrein extensively is present in many tissues such as kidney, pancreas, gastrointestinal tract mucous and central nervous system, it is synthetic in tissue with the form of prekallikrein, activate the formative tissue kallikrein through trypsinase again, and can be released into blood circulation.Tissue kallikrein acts on prokinin, makes it to discharge to generate the active result pancreokinin, and can enter blood plasma, generates bradykinin through the aminopeptidase hydrolysis.Have special receptor bound energy rising nitrogen protoxide (NO) on vasoactive bradykinin and the target organ, prostacyclin, EDHF (the endothelium derivation hyperpolarization factor) and tPA, produce vasodilation, bring high blood pressure down, a series of biological effects such as antiproliferative, anti-oxidation stress.The generation of kassinin kinin depends primarily on the activity and the quantity of kallikrein.
Bradykinin and pancreokinin are one of vasodilator substances the strongest in the body.The intravenous injection bradykinin can cause the diastole of whole body arteriole, significantly reduces the peripheral blood vessel circulation resistance, and vascular permeability strengthens, thereby causes blood pressure drops.Bradykinin also has powerful diuresis sodium effect, and the renal blood flow amount is increased, and PCP increases, and suppress uriniferous tubules and absorb again, and by stimulating afferent glomerular arteriole pressure receptor and macula densa to produce the effect of diuresis sodium.On the other hand, bradykinin can suppress distal renal tubular sodium and water are heavily absorbed and suppress the effect of antidiuretic hormone, thereby promotes the water sodium excretion.
At part primary hypertension patient and spontaneous hypertensive rat, the level of kallikrein all significantly reduces in the urine.Epidemiological study finds that also the kallikrein level is low than white man in Black people's urine, and the hypertensive sickness rate of Black people is also than white man's height.Essential hypertension and renal hypertension patient, blood vessel strengthens the step-down significant reaction of bradykinin, thereby prompting lacks the endogenous kassinin kinin.Other has the research report, and the antihypertensive function of angiotensin converting enzyme inhibitor increases relevant with kassinin kinin level in the body.Because use kassinin kinin antibody simultaneously, its hypotensive effect just obviously weakens.After low renin type essential hypertension was used angiotensin converting enzyme inhibitor, the kidney kallikrein kinin system is active to be increased, and the renal blood flow amount increases simultaneously, had report to think that its hypotensive effect mainly is owing to increased the plasmakinin level.Therefore, essential hypertension may be lowly relevant with the tissue kallikrein systematicness.
Molecule genetics research finds, (single nucleotidepolymorphism SNP) can modify the function of individual gene to mononucleotide polymorphic, causes the hypertension phenotype of determining.Infer that thus the base mutation on the DNA may change the expression of specific gene or the function of its proteins encoded.Studies show that in spontaneously hypertensive rat model, the KLK1 gene polymorphic is relevant with blood pressure regulation.Transgenic animal cross expresses human KLK1 gene generation ypotension phenotype.Afterwards, one is studies show that of basis with 57 Utah, in dominant allele and the urine tissue kallikrein's activity increase with hypertension incidence dangerous reduce relevant, prompting influence that key-gene effect of UK excretory can explain that this proterties always makes a variation 51%.Berge in 1991 and Berg have reported in the TaqI of Norwegian's group discovery restriction fragment length polymorphism and Arg53His missense mutation, but have not found that TaqI is polymorphic related with the blood pressure existence.HYPERGENE in the works people such as Slim study Arg53His is polymorphic, find that the urine tissue kallikrein activity of this polymorphic heterozygous individual is significantly higher than other individualities.Richards etc. and Song etc. are the Caucasian, non-descendants American and Aisa people find in 108 objects altogether, have a polymorphic zone before the KLK1 gene 5 ' regional transcription initiation site between-121 to-133 Nucleotide, afterwards discover that this polymorphic zone is relevant with hypertension.
Rs5517 is positioned at KLK1 gene the 4th exon, and is polymorphic for A/G, and (Lys is AAA) to L-glutamic acid (Glu, change GAA) can to cause the 186th amino acid lysine.Relation between KLK1 gene rs5517 site variation at present and essential hypertension, and detection method, test kit and the application prospect in prediction and new drug development thereof that should make a variation still do not have patent report both at home and abroad.
Summary of the invention
The present invention relates to detect the KLK1 gene rs5517 polymorphic method relevant with essential hypertension, this method comprises the A/G polymorphism of 3812 (the 60th bit bases of the 4th exon) detecting the KLK1 gene coded sequence, wherein the ill relative risk of allelic distribution frequency of A and essential hypertension is proportionate, the distribution frequency that is allelotrope A is high more, and the relative risk of suffering from essential hypertension is high more.
Pleomorphism site of the present invention by biomedical data storehouse-NIH of world authority (NCBI, Http:// www.ncbi.nlm.nih.gov) include, be the variation of A/G, (Lys is AAA) to L-glutamic acid (Glu, change GAA) can to cause the 186th amino acid lysine.This polymorphic the 4th exon that is positioned at the KLK1 gene, exon sequence is as follows, and wherein the 60th of marking of italics is rs5517 (referring to Fig. 2).This pleomorphism site can be determined by unique on human genome, be positioned 3812 of genes encoding.Polymorphic gene of the present invention and encoded protein thereof be respectively referring to the SEQID NO:1 in the sequence table, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4.
Polymorphism is meant on the locus and has a plurality of allelotrope.On some locus, body can have two allelotrope one by one.Epidemiological study shows that essential hypertension is relevant with inherited genetic factors, and father and mother are starkly lower than the probability that father and mother all have the hyperpietic for its children of normal arterial pressure person suffer from hypertensive probability.The contriver is by selecting Jilin, Beijing, Shandong, Shaanxi, Guizhou, Fujian, Hubei, Sichuan, Guangxi etc. 2411 of totally 9 provinces and cities independently hypertension is individual and age-based, sex, independently contrast is individual for 2348 of residence couplings, the laggard performing PCR amplification target gene of taking a sample, and carry out the restriction fragment length polymorphism analysis, wherein genotype is GG person, case group and control group respectively have 808 and 859 examples, genotype is AG person, case group and control group have 1114 example and 1094 examples respectively, and genotype is AA person, and case group and control group have 451 example and 364 examples respectively, the A gene frequency of case group is 42.48%, the A gene frequency of control group is 39.32%, and the P value is 0.0019, has the significance difference.It is the highest that AA genotype person suffers from hypertensive probability, under allelic recessive model with respect to A, compare with G allelotrope carrier (AG and GG genotype person), it is 1.26 times that AA genotype carrier suffers from hypertensive danger, has shown that KLK1 gene rs5517 polymorphic (A/G) is relevant with essential hypertension.Judge thus, the relative risk that essential hypertension takes place the polymorphic A allelotrope of KLK1 gene rs5517 carrier significantly raises, and the discovery of the polymorphic site relevant with essential hypertension of the present invention has great importance for hypertensive diagnosis, prevention and treatment.
In a particular, the invention provides the KLK1 gene rs5517 polymorphic method relevant that detect with essential hypertension, this method comprises design primer amplification target gene and utilizes the restriction fragment length polymorphism method to identify the polymorphic genotype of KLK1 gene rs5517 that wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
The primer of Shi Yonging comprises the oligonucleotide of sufficient length and suitable sequence in the present invention, is used to target nucleotide to synthesize special beginning is provided.This primer can comprise for example 15-30 Nucleotide, and generally complementary with every chain of the nucleotide sequence that will increase, and for example is
5’CAGTGAAGCAGATGCCTGGT 3’,
5’TCCTGCCTAATGATGAGTTC 3’。
Restriction fragment length polymorphism is with genomic dna or the some gene of a certain restriction enzyme cutting from Different Individual, because polymorphic genotype, and obtain the dna fragmentation of different lengths and number, differently determine different polymorphic genotype by what detect DNA length after enzyme is cut and number.
In another particular, the invention provides the KLK1 gene rs5517 polymorphic method relevant that detect with essential hypertension, this method comprises design primer amplification target gene and adopts direct sequencing to measure KLK1 gene rs5517 polymorphic, and wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
In another particular, the invention provides the KLK1 gene rs5517 polymorphic method relevant that detect with essential hypertension, this method comprises design primer amplification target gene and adopts the polymorphic genotype of nucleic acid probe determining KLK1 gene rs5517 of mark that wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
Nucleic acid probe can be used radio isotope, enzyme, luminescent material (for example fluorescence and phosphor material) mark.These radio isotope, enzyme, luminescent material that are used for mark etc. are that those skilled in the art is known, for example but be not limited to 32P, 125I, 14C, horseradish peroxidase, fluorescein etc.Nucleic acid probe can be the gene order complementation of G with polymorphic gene locus, can be the gene order complementation of A with polymorphic gene locus also.Perhaps, can exist simultaneously with polymorphic gene locus be the gene order of G complementary and with polymorphic gene locus be two kinds of nucleic acid probes of gene order complementary of A.The length of probe for example can be 10-50 or polybase base more, or 15-30 base.For example, in one embodiment, probe can be the nucleic acid fragment with the nucleic acid array complementation of Fig. 2.
Except above method, can also adopt well known by persons skilled in the art other to detect the method for polymorphic site.
The present invention also provides and can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, and this test kit mainly comprises the dNTP that is used for PCR, primer, the Taq enzyme, dna profiling, and the restriction endonuclease that is used for the restriction fragment length polymorphism method, for example Taq I restriction endonuclease.
In addition, the invention provides and can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, this test kit mainly comprises the dNTP that is used for PCR, primer, the Taq enzyme, dna profiling, and the labeling nucleic acid probe that is used to detect the gene polymorphic site.
In addition, the invention provides and can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, this test kit mainly comprises the dNTP that is used for PCR, primer, the Taq enzyme, dna profiling, and the sequencing kit that is used to detect the gene polymorphic site.
For example, according to a specific embodiment, test kit contains the following reagent that is useful on PCR:
Primer:
5’CAGTGAAGCAGATGCCTGGT 3’,
5 ' TCCTGCCTAATGATGAGTTC, 3 ' each 0.2 μ l (5 μ M),
dNTP MIX 0.4μl(10mM),
Taq enzyme 0.1 μ l (5u/ μ l),
PCR buffer 1.0μl(10X),
Dna profiling 1.0 μ l (10ng/ μ l);
Contain the following reagent that is useful on the restriction fragment length polymorphism method in addition:
Taq I buffer 1.5 μ l (10X); With
Taq I 0.1μl(10u/μl)。
The using method that is used to detect the polymorphic test kit of the KLK1 gene rs5517 relevant with essential hypertension of the present invention comprises the following steps: A, obtains biological specimen from live body, by above-mentioned PCR primer, carries out pcr amplification reaction; B, purifying PCR reaction product are with restriction enzyme inscribe PCR reaction product; C, electrophoresis evaluation enzyme are cut dna fragmentation.
KLK1 gene rs5517 proposed by the invention is polymorphic can be detected in such as blood, living tissue at human sample.Method of the present invention can be used to carry out examination in the crowd, thereby can judge the relative risk of suffering from essential hypertension according to the polymorphic genotype of KLK1 gene rs5517 of individuality.Simultaneously, can also adopt this method early diagnosis essential hypertension.By detecting this gene polymorphic, for hypertension excessive risk individuality, can take preventive measures early, prevent hypertensive generation.
In case essential hypertension is the stubborn disease that a kind of ill need are taken medicine throughout one's life, does not still have treatment means completely at present.Hypertension is modal cardiovascular disorder, morbidity height not only, and can cause the serious heart, brain, kidney complication, be a kind of to the great disease of human health risk.The proposition in essential hypertension gene polymorphic of the present invention site provides a kind of new approach for thoroughly treating essential hypertension.By correcting polymorphic genetic flaw,, might reach prevention or treat hypertensive purpose perhaps by reducing or eliminating defective KLK1 gene product.Therefore, the KLK1 gene rs5517 polymorphic proposition relevant with essential hypertension of the present invention provides possibility for developing essential hypertension gene therapy medicament and gene therapy method.And the proposition in gene polymorphic of the present invention site for the cause of disease of essential hypertension has proposed new viewpoint, has been deepened the understanding to the essential hypertension disease.
Description of drawings
Fig. 1 shows the structural representation of KLK1 gene.
Fig. 2 shows the gene order of the 4th exon of KLK1 gene, this polymorphic the 4th exon that is positioned at the KLK1 gene, and wherein the 60th of marking of italics is rs5517, is the variation of A/G.
Fig. 3 shows genotype electrophoresis synoptic diagram, and the right side band is Marker, i.e. the standard electrophoretogram.When rs5517 is polymorphic when A allelotrope occurring, electrophoresis is the band of 194bp, and when G allelotrope occurring, electrophoresis is two bands of 174bp and 20bp.
Embodiment
1, detects polymorphic test sample and the method for rs5517
Combine with the restriction fragment length polymorphism method by PCR that to detect rs5517 polymorphic.
1.1 the acquisition of test sample
All dna samples and clinical data all from the international cardiovascular diseases cooperating research in Asia (the International Collaborative Study of Cardiovascular Disease in Asia, InterASIA).The approval of local Ethics Committee has been passed through in this plan, and each participant has signed Informed Consent Form voluntarily.Have 15,838 volunteers of representational 35 to 74 years old have participated in this plan, we have therefrom selected Jilin, Beijing, Shandong, Shaanxi, Guizhou, Fujian, Hubei, Sichuan, Guangxi etc. 2411 of totally 9 provinces and cities independently hypertension individual and by sex, age, independently contrast is individual for 2348 of residence couplings.The participator all fills out a questionnaire in detail, comprises disease personal history, family history, smoking and history of drinking history and drug use situation, and measures height, body weight, waistline and every biochemical indicators such as hip circumference and blood plasma lipide.Every volunteer's blood pressure is all by doing some training very often and measuring three times by the investigator who authenticates.All research objects are Han nationality and consanguinity-less relation.This study selected hypertensive being defined as: systolic pressure 〉=150mmHg and or diastolic pressure 〉=95mmHg; But take depressor systolic pressure<150mmHg, diastolic pressure<95mmHg.The individuality of suffering from secondary sexual type hypertension, coronary heart disease and diabetes is not within the field of investigation.
1.2rs5517 the acquisition of polymorphic amplified fragments
By the mispairing primer of design, use the precious biotechnology Taq of company limited of 9700PCR instrument and the Dalian enzyme of ABI company to carry out polymerase chain reaction (PCR) the acquisition polymorphic amplified fragments of rs5517 (194bp).Amplimer and amplification condition see Table 1 and table 2.
The amplimer that table 1 rs5517 is polymorphic
Primer Sequence
The downstream, upstream 5’CAGTGAAGCAGATGCCTGGT 3’ 5’TCCTGCCTAATGATGAGTTC 3’
Polymorphic pcr amplification system of table 2 rs5517 and amplification condition
The amplification system composition Consumption Amplification condition
10 μ l Dna profiling PCR buffer dNTP MIX primer Taq enzyme water 1.0 each 0.2 μ l (5 μ M), 0.1 μ l (5u/ μ l), 7.1 μ l of μ l (10ng/ μ l) 1.0 μ l (10 *) 0.4 μ l (10mM) Pre-94 ℃ of 5min of sex change, 94 ℃ of 15s of sex change, 58 ℃ of 15s anneal, extend 72 ℃ of 30s, react 40 circulations, extend 72 ℃ of 10min at last.
1.3 the restriction fragment length polymorphism method is identified the polymorphic genotype of rs5517
After containing the polymorphic dna fragmentation of rs5517 and increasing successfully, with restriction enzyme product is carried out enzyme and cut, can tell the genotype in this site from gel electrophoresis spectrum.
Taq I restriction endonuclease with the precious biotechnology in Dalian company limited makes the amplified production of 194bp cut 10h at 65 ℃ of enzymes.The enzyme system of cutting sees Table 3.
The polymorphic enzyme of table 3 rs5517 is cut system and enzyme tangent condition
Enzyme is cut the system composition Consumption The enzyme tangent condition
15μl PCR product Taq I Taq I buffer water 10μl 0.1μl(10u/μl) 1.5μl(10×) 3.4μl 65℃ 10h
1.4 agarose gel electrophoresis inspection enzyme is cut product
In the concentration of ethidium bromide staining is that electrophoresis enzyme is cut product in 3% the sepharose, and 250 volts of voltages, electrophoresis time are 50 minutes.When rs5517 is polymorphic when A allelotrope occurring, electrophoresis is the band of 194bp, and when G allelotrope occurring, electrophoresis is two bands of 174bp and 20bp.Fig. 3 shows genotype electrophoresis synoptic diagram, and the right side band is Marker, i.e. the standard electrophoretogram.
The dependency of the polymorphic and human essential hypertension of 2rs5517
2.1 case-control sample Clinical symptoms is described
The sex of case group and control group, age, smoking rate and the difference of drinking rate there are no significant.Compare the weight index of case group (BMI), total cholesterol (CHO) with control group, triglyceride level (TG), blood sugar (Glu), low density lipoprotein cholesterol (LDL_C), (Cr) is higher for creatinine level, and high density lipoprotein cholesterol (HDL_C) level is lower, all has significant difference.See Table 4.
Table 4 case-control sample Clinical symptoms is described
Case (n=2411) Contrast (n=2348) The P value
Age (year) sex, man/women systolic pressure, the mmHg diastolic pressure, the mmHg weight index, kg/m 2Total cholesterol, the mg/dl triglyceride level, mg/dl blood sugar, the mg/dl high density lipoprotein cholesterol, the mb/dl low density lipoprotein cholesterol, the mg/dl serum creatinine, μ mol/L smoker alcohol user 54.60±10.11 1206/1205 149.05±22.14 90.62±12.08 25.22±3.66 198.23±37.89 139.03±65.73 98.87±18.21 49.19±12.82 121.32±34.59 72.68±14.77 915 749 54.16±9.34 1198/1150 114.35±10.19 73.28±7.45 23.15±3.45 190.26±39.18 120.06±58.09 95.24±17.37 51.01±12.75 115.30±35.38 71.60±13.01 952 716 0.122 0.49 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.002 0.008 0.067 0.678
Numerical value is means standard deviation
2.2rs5517 polymorphic frequency distribution in the case-control sample
The difference that the polymorphic three kinds of genotype of rs5517 distribute in case and contrast has significance.The frequency of A allelotrope in case is apparently higher than control group, and difference has significance.See Table 5.
The polymorphic frequency distribution in the case-control sample of table 5 rs5517
Genotype Case (n=2411) Contrast (n=2348) The P value
GG AG AA 808 1114 451 859 1094 364 0.0056
A gene frequency (%) 42.48 39.32 0.0019
2.3rs5517 polymorphic and hypertensive relative risk
Under the allelic recessive inheritance model (promptly merging two kinds of genotype of GG and AG) with respect to A, the individual danger that essential hypertension takes place of AA genotype significantly raises than G allelotrope carrier.Carry out the non-conditional Logistic Regression of multivariate, adjust the age, sex, smoking is drunk, BMI, TG, CHO, Glu, Cr, after the conventional risk factors such as HDL_C, rs5517 recessive inheritance model still keeps significantly related with hypertensive generation.The carrier compares with G allelotrope, and hypertensive risk takes place AA genotype carrier has increased by 25%, sees Table 6.
The polymorphic relative risk of table 6 rs5517 with respect to essential hypertension
Genotype Case (n=2411) Contrast (n=2348) OR value (95%CI) P value #OR value (95%CI) #P value
AG+GG AA 1922 451 1953 364 - 1.26(1.08,1.47) P=0.0029 - 1.25(1.07,1.47) P=0.0063
# is for after adjusting traditional environmental risk factor
3 are used to detect the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension
3.1 primer:
5’CAGTGAAGCAGATGCCTGGT 3’,
5 ' TCCTGCCTAATGATGAGTTC, 3 ' each 0.2 μ l (5 μ M),
dNTP MIX 0.4μl(10mM),
Taq enzyme 0.1 μ l (5u/ μ l),
PCR buffer 1.0μl(10X),
Dna profiling 1.0 μ l (10ng/ μ l);
3.2 contain the following reagent that is useful on the restriction fragment length polymorphism method in addition:
Taq I buffer 1.5 μ l (10X); With
Taq I 0.1μl(10u/μl)。
3.3 operation steps
3.3.1 obtain biological specimen from live body,, carry out pcr amplification reaction by above-mentioned PCR primer.
3.3.2 purifying PCR reaction product is with digestion with restriction enzyme PCR reaction product.
3.3.3 electrophoresis evaluation enzyme is cut dna fragmentation.
4 are used to detect the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension
This test kit comprises:
Primer:
5’CAGTGAAGCAGATGCCTGGT 3’,
5 ' TCCTGCCTAATGATGAGTTC, 3 ' each 0.2 μ l (5 μ M),
dNTP MIX 0.4μl(10mM),
Taq enzyme 0.1 μ l (5u/ μ l),
PCR buffer 1.0μl(10X),
Dna profiling 1.0 μ l (10ng/ μ l);
Operation steps
A, obtain biological specimen,, carry out pcr amplification reaction by above-mentioned PCR primer from live body.
B, purifying PCR reaction product directly check order to the PCR reaction product.
SEQUENCE LISTING
<110〉Sinogenomax Co., Ltd.
<120〉detect the KLK1 gene rs5517 polymorphic method relevant with essential hypertension
<130>
<160>4
<170>PatentIn version 3.1
<210>1
<211>4640
<212>DNA
<213〉people
<400>1
agttcctcca cctgctggcc cctggacacc tctgtcacca tgtggttcct ggttctgtgc 60
ctcgccctgt ccctgggggg gactggtgag acagtggggg gatgtgggag ggggaacggg 120
ccctgattct cttgctggcc tcacatcccc ccccgataag accttcccct ccaacacccc 180
accctcatcc ctctggccca cagtctatcc tagtccgggg tgccccggct cttatctatc 240
ttgcgcggcc ccaccctaaa cttccacccc cgctcctcca tgttgtcata gtgctcactc 300
ccacaccaga ttcctgctcc tcccaggaag cctcagtact ttctcctctt ccctagccaa 360
cgccctgtcc caccgcttta ccaaaggggc agattctggg ccatctctgt ctctctctgg 420
aggaccccaa ccctcccatg ggcttccccc accccacagg actctgatca tcccctcctg 480
ccccctagtt ccctgcggcc acctatttgg ctcctgagtc tacaaatccc accacactcc 540
agtgactttt tccatccagc tgtccgctct caactgtgtc ctccagaccc tgacatctgg 600
tctccccagt ccttccaggg tcccccaaat ttcaccagaa aaccctgctt cccaaactgg 660
catgtgggat cccccatctg gtatgggggg gggtctgcaa atgtcccttc ccacccagca 720
cccccagctc tcccaggaaa aacaccacac cctcccacca catgctcctt tccttgggga 780
agttccatcc cgccccaggc cccagccctt ctctgcctga attgttccta cacagctctg 840
gttttctgga accccacccc aaggatcctg aatgccttct cagccagcgc ttctgccctg 900
gcctccccca agtcagtatg tgattctaca acctcacgtc aagtgggtcc tgcattgcat 960
tcccacagct gcttggcgcc tgttctcacc acttctccaa tcctcttcct aggattgcct 1020
ccaagaggac cccatatcct tccagtaccc tcagaccatg aaccccatcc ccatgagaaa 1080
cgaagatccc atccttcacc ctgtccgaga aggactgcca ctcacgcctc cctcctcctg 1140
agccccgtcc cagtcctgac cgcaactgtg ttctcagggc cccaacctcc cctcagattg 1200
ccattcctgg ttcacaggaa ggaccccaaa acctctcgga agcccacctc tagccttaac 1260
catagccctt tcttttaccc tttaaccagg aagccctgaa atctaactgt cccagccaag 1320
ctggcccctt ccaaccccaa tgtagggacc ccaagtcacc cccaaactct tcagtccaga 1380
tgctcttctt tacctctcag acctggttcc ctaaagctgc atcctttcct gaacctcaaa 1440
agcccaaccc aggtcctgtt tccctagcct aggagcccct tagccctcca gattcttcct 1500
cagtgagcct ctgatcctgt cccacccttg gcgccttgat ccctggtttc cagaatccct 1560
ttccactccc ctaacccacc acctcccatc ccccagcccc agaccccaaa tgacctgacg 1620
cccagatgca gtgtctgctc cagacactgt ctcctgtctc ctaccctgat ccctggaggc 1680
tgctctactg tcagagcaca aaatctcccc accaggtcca gccaccactc caaaagccca 1740
gggaacagtc cagagtccca ccccttccca acaccccttg cccatgtccc caacctccag 1800
ccctggtcct ctacccgcaa tgtcccttca gacccacagc ccagctccct ctcctagcct 1860
tgtccctggc ctctcctgcc aaccctgccc ttcctgaccc agcaccgcct ctgcaggtgc 1920
tgcgcccccg attcagtccc ggattgtggg aggctgggag tgtgagcagc attcccagcc 1980
ctggcaggcg gctctgtacc atttcagcac tttccagtgt gggggcatcc tggtgcaccg 2040
ccagtgggtg ctcacagctg ctcattgcat cagcgagtga gtaggggcct ggggtctggg 2100
aggagggcat ctatgctgcc acaggattga caggccagtg gcattcccct tggataacct 2160
caggcaagac tggggggctg aggcagagag gaaggctctg gcgcaggtcg cctggcaggg 2220
cagagctggg ctggacaccc ctctccaagg ctgcctgggt ctcttgggat ctggttctgc 2280
ttgtgtctct gtgtgactgt gttctggtct ctgtcttcct ctctctcctc tgtctccttg 2340
tctctgcatc tcccctgtct ctgtctgtct ctgagtctct ctgcggcatc tctgtcactg 2400
tgtctcaccc tccatctctc tacccatctc tctctctctg ggtctctacc tcaccgctcc 2460
ctcatcccta ctaaacacac acccagatgg acctaaggga ggccccagag taaaggaagg 2520
gctttatccc caacttgtgt gcctgggagg gggcgcctct ccctctgtcc agctccccgc 2580
cccacaggat atccctccac tctggagaga cacagggaag ggctggtttc agcgggagct 2640
gggtggggca actgagggag gaggaaggag gaggcggggc gagaaacgcg cgggagggtg 2700
ctgggaaggg aagggggcct cgaccttgga cttcaggcca ggccacctgc ccctggggag 2760
cccgcaccac agccccagct gcagctgagc cgctctcagg cctcccctcc tccctacctg 2820
cccccaccct ccccacctgc ccccaccctc ccccagggcc tccctccctt ttctctccca 2880
cactcggtca ctcctgcttc ctctctgcct ctgtttctag ttctcactct gacgtcccgc 2940
gtcctttttc atttgtctgc ttctcgctcc cttccgtgtt ctgttccctc ttcctccctc 3000
ttccctgggc ctgtttctcg ctgtccctgt cttttatcct tctcatctgc ctcttttttg 3060
ctcaccctgt ttctcactgc cctcccctcc gcctttttca cccctctgtc cttttgagct 3120
cttttttgct ctgtctcttc atttgccttt tgcactctca aaatctttca tcttcccatt 3180
cgctgtctgt atttctccat aactatatct ttcttcctct gtctccgccc acccacattt 3240
ttctctttcc ctttctctct ttggggaccc tcccccatgc tcccctgccc catccccttt 3300
tccccttccc gtcttctcat ccctccattc ccatctttcc ccagcaatta ccagctctgg 3360
ctgggtcgcc acaacttgtt tgacgacgaa aacacagccc agtttgttca tgtcagtgag 3420
agcttcccac accctggctt caacatgagc ctcctggaga accacacccg ccaagcagac 3480
gaggactaca gccacgacct catgctgctc cgcctgacag agcctgctga taccatcaca 3540
gatgctgtga aggtcgtgga gttgcccacc gaggaacccg aagtggggag cacctgtttg 3600
gcttccggct ggggcagcat cgaaccagag aattgtatgt gggggcagac tgtgtagccc 3660
aaggcgggga tggggactcc tgcgtccaag ggagaaaggg ccagggaagc aggtgaggtc 3720
gggctgcagc cctttttctc ccgggttcgt agtctcattt ccagatgatc tccagtgtgt 3780
ggacctcaaa atcctgccta atgatgagtg caaaaaagcc cacgtccaga aggtgacaga 3840
cttcatgctg tgtgtcggac acctggaagg tggcaaagac acctgtgtgg tgaggcagcc 3900
ctgcccccag ggtctggaag ggctgaggga ggggactcag cctctgaact ggcttctgag 3960
agctaaccag gcatctgctt cactgcttcc cagctagctg tagccactcg ccccatcagt 4020
gccccagctc cccctccttc ccccgcccat ccagggacaa ctgcatctca ccccccacac 4080
cagagttcac cgttcctcgt ggtaatgtgt tgttaccgtc gagtcagaga gtagtcctgg 4140
agaggtggcc tctgcgatgt gcccgcaggg gcagcgtcct gcagatggtc ctgcccctcc 4200
tccccctaac ctgtctgcag gcactgtcca cctggaccct gccccatgtg caggagctgg 4260
accctgaggt cccttccccc ttggccagga ctggagaccc tgtcccctct gtgggaatcc 4320
ctgcccacct tcctctggga gtgggcactg gaggccctgt ctgcgagctg gggctcccca 4380
ggcagaactt gggccccgta gacctttctc actctcccct cccaccttgt gctcccaggg 4440
tgattcaggg ggcccgctga tgtgtgatgg tgtgctccaa ggtgtcacat catggggcta 4500
cgtcccttgt ggcaccccca ataagccttc tgtcgccgtc agagtgctgt cttatgtgaa 4560
gtggatcgag gacaccatag cggagaactc ctgaacgccc agccctgtcc cctaccccca 4620
gtaaaatcaa atgtgcatcc 4640
<210>2
<211>4640
<212>DNA
<213〉people
<400>2
agttcctcca cctgctggcc cctggacacc tctgtcacca tgtggttcct ggttctgtgc 60
ctcgccctgt ccctgggggg gactggtgag acagtggggg gatgtgggag ggggaacggg 120
ccctgattct cttgctggcc tcacatcccc ccccgataag accttcccct ccaacacccc 180
accctcatcc ctctggccca cagtctatcc tagtccgggg tgccccggct cttatctatc 240
ttgcgcggcc ccaccctaaa cttccacccc cgctcctcca tgttgtcata gtgctcactc 300
ccacaccaga ttcctgctcc tcccaggaag cctcagtact ttctcctctt ccctagccaa 360
cgccctgtcc caccgcttta ccaaaggggc agattctggg ccatctctgt ctctctctgg 420
aggaccccaa ccctcccatg ggcttccccc accccacagg actctgatca tcccctcctg 480
ccccctagtt ccctgcggcc acctatttgg ctcctgagtc tacaaatccc accacactcc 540
agtgactttt tccatccagc tgtccgctct caactgtgtc ctccagaccc tgacatctgg 600
tctccccagt ccttccaggg tcccccaaat ttcaccagaa aaccctgctt cccaaactgg 660
catgtgggat cccccatctg gtatgggggg gggtctgcaa atgtcccttc ccacccagca 720
cccccagctc tcccaggaaa aacaccacac cctcccacca catgctcctt tccttgggga 780
agttccatcc cgccccaggc cccagccctt ctctgcctga attgttccta cacagctctg 840
gttttctgga accccacccc aaggatcctg aatgccttct cagccagcgc ttctgccctg 900
gcctccccca agtcagtatg tgattctaca acctcacgtc aagtgggtcc tgcattgcat 960
tcccacagct gcttggcgcc tgttctcacc acttctccaa tcctcttcct aggattgcct 1020
ccaagaggac cccatatcct tccagtaccc tcagaccatg aaccccatcc ccatgagaaa 1080
cgaagatccc atccttcacc ctgtccgaga aggactgcca ctcacgcctc cctcctcctg 1140
agccccgtcc cagtcctgac cgcaactgtg ttctcagggc cccaacctcc cctcagattg 1200
ccattcctgg ttcacaggaa ggaccccaaa acctctcgga agcccacctc tagccttaac 1260
catagccctt tcttttaccc tttaaccagg aagccctgaa atctaactgt cccagccaag 1320
ctggcccctt ccaaccccaa tgtagggacc ccaagtcacc cccaaactct tcagtccaga 1380
tgctcttctt tacctctcag acctggttcc ctaaagctgc atcctttcct gaacctcaaa 1440
agcccaaccc aggtcctgtt tccctagcct aggagcccct tagccctcca gattcttcct 1500
cagtgagcct ctgatcctgt cccacccttg gcgccttgat ccctggtttc cagaatccct 1560
ttccactccc ctaacccacc acctcccatc ccccagcccc agaccccaaa tgacctgacg 1620
cccagatgca gtgtctgctc cagacactgt ctcctgtctc ctaccctgat ccctggaggc 1680
tgctctactg tcagagcaca aaatctcccc accaggtcca gccaccactc caaaagccca 1740
gggaacagtc cagagtccca ccccttccca acaccccttg cccatgtccc caacctccag 1800
ccctggtcct ctacccgcaa tgtcccttca gacccacagc ccagctccct ctcctagcct 1860
tgtccctggc ctctcctgcc aaccctgccc ttcctgaccc agcaccgcct ctgcaggtgc 1920
tgcgcccccg attcagtccc ggattgtggg aggctgggag tgtgagcagc attcccagcc 1980
ctggcaggcg gctctgtacc atttcagcac tttccagtgt gggggcatcc tggtgcaccg 2040
ccagtgggtg ctcacagctg ctcattgcat cagcgagtga gtaggggcct ggggtctggg 2100
aggagggcat ctatgctgcc acaggattga caggccagtg gcattcccct tggataacct 2160
caggcaagac tggggggctg aggcagagag gaaggctctg gcgcaggtcg cctggcaggg 2220
cagagctggg ctggacaccc ctctccaagg ctgcctgggt ctcttgggat ctggttctgc 2280
ttgtgtctct gtgtgactgt gttctggtct ctgtcttcct ctctctcctc tgtctccttg 2340
tctctgcatc tcccctgtct ctgtctgtct ctgagtctct ctgcggcatc tctgtcactg 2400
tgtctcaccc tccatctctc tacccatctc tctctctctg ggtctctacc tcaccgctcc 2460
ctcatcccta ctaaacacac acccagatgg acctaaggga ggccccagag taaaggaagg 2520
gctttatccc caacttgtgt gcctgggagg gggcgcctct ccctctgtcc agctccccgc 2580
cccacaggat atccctccac tctggagaga cacagggaag ggctggtttc agcgggagct 2640
gggtggggca actgagggag gaggaaggag gaggcggggc gagaaacgcg cgggagggtg 2700
ctgggaaggg aagggggcct cgaccttgga cttcaggcca ggccacctgc ccctggggag 2760
cccgcaccac agccccagct gcagctgagc cgctctcagg cctcccctcc tccctacctg 2820
cccccaccct ccccacctgc ccccaccctc ccccagggcc tccctccctt ttctctccca 2880
cactcggtca ctcctgcttc ctctctgcct ctgtttctag ttctcactct gacgtcccgc 2940
gtcctttttc atttgtctgc ttctcgctcc cttccgtgtt ctgttccctc ttcctccctc 3000
ttccctgggc ctgtttctcg ctgtccctgt cttttatcct tctcatctgc ctcttttttg 3060
ctcaccctgt ttctcactgc cctcccctcc gcctttttca cccctctgtc cttttgagct 3120
cttttttgct ctgtctcttc atttgccttt tgcactctca aaatctttca tcttcccatt 3180
cgctgtctgt atttctccat aactatatct ttcttcctct gtctccgccc acccacattt 3240
ttctctttcc ctttctctct ttggggaccc tcccccatgc tcccctgccc catccccttt 3300
tccccttccc gtcttctcat ccctccattc ccatctttcc ccagcaatta ccagctctgg 3360
ctgggtcgcc acaacttgtt tgacgacgaa aacacagccc agtttgttca tgtcagtgag 3420
agcttcccac accctggctt caacatgagc ctcctggaga accacacccg ccaagcagac 3480
gaggactaca gccacgacct catgctgctc cgcctgacag agcctgctga taccatcaca 3540
gatgctgtga aggtcgtgga gttgcccacc gaggaacccg aagtggggag cacctgtttg 3600
gcttccggct ggggcagcat cgaaccagag aattgtatgt gggggcagac tgtgtagccc 3660
aaggcgggga tggggactcc tgcgtccaag ggagaaaggg ccagggaagc aggtgaggtc 3720
gggctgcagc cctttttctc ccgggttcgt agtctcattt ccagatgatc tccagtgtgt 3780
ggacctcaaa atcctgccta atgatgagtg cgaaaaagcc cacgtccaga aggtgacaga 3840
cttcatgctg tgtgtcggac acctggaagg tggcaaagac acctgtgtgg tgaggcagcc 3900
ctgcccccag ggtctggaag ggctgaggga ggggactcag cctctgaact ggcttctgag 3960
agctaaccag gcatctgctt cactgcttcc cagctagctg tagccactcg ccccatcagt 4020
gccccagctc cccctccttc ccccgcccat ccagggacaa ctgcatctca ccccccacac 4080
cagagttcac cgttcctcgt ggtaatgtgt tgttaccgtc gagtcagaga gtagtcctgg 4140
agaggtggcc tctgcgatgt gcccgcaggg gcagcgtcct gcagatggtc ctgcccctcc 4200
tccccctaac ctgtctgcag gcactgtcca cctggaccct gccccatgtg caggagctgg 4260
accctgaggt cccttccccc ttggccagga ctggagaccc tgtcccctct gtgggaatcc 4320
ctgcccacct tcctctggga gtgggcactg gaggccctgt ctgcgagctg gggctcccca 4380
ggcagaactt gggccccgta gacctttctc actctcccct cccaccttgt gctcccaggg 4440
tgattcaggg ggcccgctga tgtgtgatgg tgtgctccaa ggtgtcacat catggggcta 4500
cgtcccttgt ggcaccccca ataagccttc tgtcgccgtc agagtgctgt cttatgtgaa 4560
gtggatcgag gacaccatag cggagaactc ctgaacgccc agccctgtcc cctaccccca 4620
gtaaaateaa atgtgcatcc 4640
<210>3
<211>262
<212>PRT
<213〉people
<400>3
Met Trp Phe Leu Val Leu Cys Leu Ala Leu Ser Leu Gly Gly Thr Gly
1 5 10 15
Ala Ala Pro Pro Ile Gln Ser Arg Ile Val Gly Gly Trp Glu Cys Glu
20 25 30
Gln His Ser Gln Pro Trp Gln Ala Ala Leu Tyr His Phe Ser Thr Phe
35 40 45
Gln Cys Gly Gly Ile Leu Val His Arg Gln Trp Val Leu Thr Ala Ala
50 55 60
His Cys Ile Ser Asp Asn Tyr Gln Leu Trp Leu Gly Arg His Asn Leu
65 70 75 80
Phe AspAsp Glu Asn Thr Ala Gln Phe Val His Val Ser Glu Ser Phe
85 90 95
Pro His Pro Gly Phe Asn Met Ser Leu Leu Glu Asn His Thr Arg Gln
100 105 110
Ala Asp Glu Asp Tyr Ser His Asp Leu Met Leu Leu Arg Leu Thr Glu
115 120 125
Pro Ala Asp Thr Ile Thr Asp Ala Val Lys Val Val Glu Leu Pro Thr
130 135 140
Glu Glu Pro Glu Val Gly Ser Thr Cys Leu Ala Ser Gly Trp Gly Ser
145 150 155 160
Ile Glu Pro Glu Asn Phe Ser Phe Pro Asp Asp Leu Gln Cys Val Asp
165 170 175
Leu Lys Ile Leu Pro Asn Asp Glu Cys Lys Lys Ala His Val Gln Lys
180 185 190
Val Thr Asp Phe Met Leu Cys Val Gly His Leu Glu Gly Gly Lys Asp
195 200 205
Thr Cys Val Gly Asp Ser Gly Gly Pro Leu Met Cys Asp Gly Val Leu
210 215 220
Gln Gly Val Thr Ser Trp Gly Tyr Val Pro Cys Gly Thr Pro Asn Lys
225 230 235 240
Pro Ser Val Ala Val Arg Val Leu Ser Tyr Val Lys Trp Ile Glu Asp
245 250 255
Thr Ile Ala Glu Asn Ser
260
<210>4
<211>262
<212>PRT
<213〉people
<400>4
Met Trp Phe Leu Val Leu Cys Leu Ala Leu Ser Leu Gly Gly Thr Gly
1 5 10 15
Ala Ala Pro Pro Ile Gln Ser Arg Ile Val Gly Gly Trp Glu Cys Glu
20 25 30
Gln His Ser Gln Pro Trp Gln Ala Ala Leu Tyr His Phe Ser Thr Phe
35 40 45
Gln Cys Gly Gly Ile Leu Val His Arg Gln Trp Val Leu Thr Ala Ala
50 55 60
His Cys Ile Ser Asp Asn Tyr Gln Leu Trp Leu Gly Arg His Asn Leu
65 70 75 80
Phe Asp Asp Glu Asn Thr Ala Gln Phe Val His ValSer Glu Ser Phe
85 90 95
Pro His Pro Gly Phe Asn Met Ser Leu Leu Glu Asn His Thr Arg Gln
100 105 110
Ala Asp Glu Asp Tyr Ser His Asp Leu Met Leu Leu Arg Leu Thr Glu
115 120 125
Pro Ala Asp Thr Ile Thr Asp Ala Val Lys Val Val Glu Leu Pro Thr
130 135 140
Glu Glu Pro Glu Val Gly Ser Thr Cys Leu Ala Ser Gly Trp Gly Ser
145 150 155 160
Ile Glu Pro Glu Asn Phe Ser Phe Pro Asp Asp Leu Gln Cys Val Asp
165 170 175
Leu Lys Ile Leu Pro Asn Asp Glu Cys Glu Lys Ala His Val Gln Lys
180 185 190
Val Thr Asp Phe Met Leu Cys Val Gly His Leu Glu Gly Gly Lys Asp
195 200 205
Thr Cys Val Gly Asp Ser Gly Gly Pro Leu Met Cys Asp Gly Val Leu
210 215 220
Gln Gly Val Thr Ser Trp Gly Tyr Val Pro Cys Gly Thr Pro Asn Lys
225 230 235 240
Pro Ser Val Ala Val Arg Val Leu Ser Tyr Val Lys Trp Ile Glu Asp
245 250 255
Thr Ile Ala Glu Asn Ser
260

Claims (10)

1, the polymorphic method of KLK1 gene rs5517 that detection is relevant with essential hypertension, this method comprises 3812 the A/G polymorphism that detects the KLK1 gene coded sequence, and wherein the ill relative risk of allelic distribution frequency of A and essential hypertension is proportionate.
2, the polymorphic method of KLK1 gene rs5517 that detection is relevant with essential hypertension, this method comprises design primer amplification target gene and utilizes the restriction fragment length polymorphism method to identify the polymorphic genotype of KLK1 gene rs5517 that wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
3, the polymorphic method of KLK1 gene rs5517 that detection as claimed in claim 2 is relevant with essential hypertension, wherein said primer is:
5’CAGTGAAGCAGATGCCTGGT 3’,
5’TCCTGCCTAATGATGAGTTC 3’。
4, the polymorphic method of KLK1 gene rs5517 that detection is relevant with essential hypertension, this method comprises design primer amplification target gene and adopts direct sequencing to measure KLK1 gene rs5517 polymorphic, and wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
5, the polymorphic method of KLK1 gene rs5517 that detection is relevant with essential hypertension, this method comprises design primer amplification target gene and adopts the polymorphic genotype of nucleic acid probe determining KLK1 gene rs5517 of mark that wherein allelic distribution frequency of A and the ill risk of essential hypertension are proportionate.
6, can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, this test kit mainly comprises the dNTP that is used for PCR, primer, the Taq enzyme, dna profiling, and the restriction endonuclease that is used for the restriction fragment length polymorphism method, for example Taq I restriction endonuclease.
7, can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, this test kit mainly comprises the dNTP that is used for PCR, primer, Taq enzyme, dna profiling, and the labeling nucleic acid probe that is used to detect the gene polymorphic site.
8, can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, this test kit mainly comprises the dNTP that is used for PCR, primer, Taq enzyme, dna profiling, and the sequencing kit that is used to detect the gene polymorphic site.
9, can be used for detecting the KLK1 gene rs5517 polymorphic test kit relevant with essential hypertension, test kit contains the following reagent that is useful on PCR:
Primer:
5’CAGTGAAGCAGATGCCTGGT 3’,
5 ' TCCTGCCTAATGATGAGTTC, 3 ' each 0.2 μ l (5 μ M),
dNTP MIX 0.4μl(10mM),
Taq enzyme 0.1 μ l (5u/ μ l),
PCR buffer 1.0μl(10X),
Dna profiling 1.0 μ l (10ng/ μ l);
Contain the following reagent that is useful on the restriction fragment length polymorphism method in addition:
Taq I buffer 1.5 μ l (10X); With
Taq I 0.1μl(10u/μl)。
10, the using method that is used to detect the polymorphic test kit of the KLK1 gene rs5517 relevant with essential hypertension comprises the following steps: A, obtains biological specimen from live body, by above-mentioned PCR primer, carries out pcr amplification reaction; B, purifying PCR reaction product are with restriction enzyme inscribe PCR reaction product; C, electrophoresis evaluation enzyme are cut dna fragmentation.
CN2006100567493A 2006-03-07 2006-03-07 Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension Expired - Fee Related CN101033487B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006100567493A CN101033487B (en) 2006-03-07 2006-03-07 Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100567493A CN101033487B (en) 2006-03-07 2006-03-07 Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension

Publications (2)

Publication Number Publication Date
CN101033487A true CN101033487A (en) 2007-09-12
CN101033487B CN101033487B (en) 2011-04-06

Family

ID=38730228

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100567493A Expired - Fee Related CN101033487B (en) 2006-03-07 2006-03-07 Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension

Country Status (1)

Country Link
CN (1) CN101033487B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101845520A (en) * 2010-05-11 2010-09-29 上海市血液中心 HPA allelic gene typing detection reagent kit
CN101892302A (en) * 2010-03-18 2010-11-24 首都医科大学附属北京安贞医院 Detection method and kit of locus rs2336384 of susceptibility gene of hypertension
CN107254539A (en) * 2011-07-29 2017-10-17 剑桥表现遗传学有限公司 Method for detecting nucleotide modification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1570138A (en) * 2003-07-16 2005-01-26 国家人类基因组南方研究中心 Cholelithiasis susceptibility detecting method and kit
CN1635142A (en) * 2003-12-26 2005-07-06 中国医学科学院基础医学研究所 Reagent kit for forecasting susceptibility of intolerance type dementia preaecox and primer used thereby

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101892302A (en) * 2010-03-18 2010-11-24 首都医科大学附属北京安贞医院 Detection method and kit of locus rs2336384 of susceptibility gene of hypertension
CN101892302B (en) * 2010-03-18 2012-09-19 首都医科大学附属北京安贞医院 Use and detection kit of locus rs2336384 of susceptibility gene of hypertension
CN101845520A (en) * 2010-05-11 2010-09-29 上海市血液中心 HPA allelic gene typing detection reagent kit
CN101845520B (en) * 2010-05-11 2012-06-06 上海市血液中心 HPA allelic gene typing detection reagent kit
CN107254539A (en) * 2011-07-29 2017-10-17 剑桥表现遗传学有限公司 Method for detecting nucleotide modification

Also Published As

Publication number Publication date
CN101033487B (en) 2011-04-06

Similar Documents

Publication Publication Date Title
CN100340674C (en) Deaf-related gene mutation and its detecting method
CN1497049A (en) Androgen receptor compound-associated protein
CN1169824C (en) Polytype gene of MXA protein and application thereof
CN101033487A (en) Method of detecting KLK1 gene rs5517 polymorphism correlated to primary hypertension
CN1635142A (en) Reagent kit for forecasting susceptibility of intolerance type dementia preaecox and primer used thereby
CN1890387A (en) Method for diagnosis and prognosis of breast cancer
CN1211486C (en) A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof
CN1891822A (en) PH gene with specific mononucleotide pleimorphism, and its detecting method and use
CN1761760A (en) Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long Q/T syndrome
CN1928083A (en) Mononucleotide polymorphism of human heterogenous substance metabolism enzyme gene and application of diagnosing and treating large intestinal cancer
CN1958605A (en) SPG3A gene mutation, encoded production, and application
CN1749415A (en) Pannonit treatment acute angina pectoris curative effect detection method and test kit
CN1281621C (en) Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point
CN1932016A (en) Polynucleotide affecting SRE activity and its coding polypeptides and use
CN1809645A (en) Method for detecting alzheimer&#39;s disease
CN1199998C (en) Human protein with suppression to cancer cell growth and its coding sequence
CN1570138A (en) Cholelithiasis susceptibility detecting method and kit
CN1824776A (en) Dilatation type cardiomyopathy diagnosis and therapeutic method and reagent used for said method
CN1242061C (en) Short finger gene
CN1182245C (en) Brachydactyly and body height associated gene
CN1279185C (en) Human hepatoma cell expression down-regulated genes and use thereof
CN1690221A (en) Method and kit for detecting susceptibility of cholelithiasis
CN1690222A (en) Method for detecting deafness-related gene mutation
CN1515686A (en) Kit for predicting susceptibility of diabetes and its primer
CN1661069A (en) Relativity between gene of angiotensin I converting enzyme and essential hypertension

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110406

Termination date: 20200307